Aldeyra Therapeutics, Inc. news

Investor announcements, newest first.

Close
Company news
Aldeyra Therapeutics, Inc.
Apr 27, 2021 at 4:00 AM UTC
Apr 27
Apr 27, 2021 at 4:00 AM UTC
Original

Aldeyra Therapeutics Achieves Statistical Significance for Primary Endpoint and All Secondary Endpoints in Phase 3 INVIGORATE Clinical Trial of Reproxalap in Allergic Conjunctivitis

  • Statistical Significance Achieved for Primary Endpoint of Ocular Itching at All Prespecified Timepoints (p